PlumX Metrics
Embed PlumX Metrics

Medicare expenditures associated with diabetes and diabetic retinopathy

Retina, ISSN: 0275-004X, Vol: 29, Issue: 2, Page: 199-206
2009
  • 37
    Citations
  • 0
    Usage
  • 30
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    37
  • Captures
    30
  • Mentions
    2
    • News Mentions
      2
      • News
        2

Most Recent News

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors

Introduction Diabetic retinopathy (DR) is a type of microangiopathy caused by diabetes mellitus (DM). DR is a leading cause of vision impairment in 25–74 years

Article Description

BACKGROUND: To estimate the expenditures for diabetic retinopathy in the United States by Medicare. METHODS: Retrospective data analysis using the 1997 through 2004 5% Medicare claims data. A case control design was used; eligible beneficiaries were 65 or older and without major ophthalmic conditions (cataract, cataract surgery, and macular degeneration) during the study period. Controls had diabetes but no evidence of diabetic retinopathy. There were two diabetic retinopathy case groups: beneficiaries with nonproliferative diabetic retinopathy (NPDR) and beneficiaries with proliferative diabetic retinopathy (PDR). Analyses quantified annual Medicare payments for case and control groups. RESULTS: A total of 178,383 controls, 33,735 NPDR cases, and 6,138 PDR cases were identified. After adjusting for age, sex, and race, annual average Medicare payments for all care were significantly higher for case groups compared to the control group, as were average payments for ophthalmic care only (all P < 0.0001). In addition, average payments for all care and for ophthalmic care were substantially higher for PDR cases compared to NPDR cases. CONCLUSION: These findings demonstrate substantial expenditures associated with diabetic retinopathy, and with PDR in particular, only part of which is due to ophthalmic care. Delaying progression may be associated with decreased Medicare expenditures. Copyright © by Ophthalmic Communications Society, Inc.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know